Is a complete PALI research report available?

No complete published report is available for Palisade Bio, Inc. (PALI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Palisade Bio, Inc. (PALI)

NASDAQ: PALI · USD

$1.95

-0.07 (-3.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PALI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	338.5M
Net income (ttm)	-24.2M
EPS (ttm)	-$0.23
Shares out	173.6M
Volume	2,333,432
Beta	1.51
Price target	$10.5	+438.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -24.2M
EPS (ttm): -$0.23
Market cap: 338.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PALI indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001357459
Company name	Palisade Bio, Inc.
Country	United States
Country code	US
Cusip	696389402
Employees	14
Employees Change	6%
Employees Change Percent	75
Enterprise value	$205.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6963894026
Last refreshed	2026-07-26
Market cap	$338.5M
Market cap category	Small-Cap
Price	$1.95
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2836
Symbol	PALI
Website	https://www.palisadebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.14%
FCF yield	-3.66%
P/B ratio	2.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-24.2M
Net Income Growth Years	0%
Profit Per Employee	$-1.7M
ROA	-23.4
Roa5y	-61.21
ROCE	-20.75
ROE	-36.4
Roe5y	-4,087.4
ROIC	-24.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	59.89%
Cagr3y	-60.62%
Cagr5y	-76.2%
EPS Growth Quarters	9
EPS Growth Years	12
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$133.3M
Cash	$132.6M
Current Assets	$133.2M
Current Liabilities	$5.6M
Debt	$0
Equity	$127.4M
Interest Coverage	-2,649.4
Liabilities	$6M
Long Term Assets	$72,000
Long Term Liabilities	$333,000
Net Cash	$132.6M
Net Cash By Market Cap	$39.18
Net Cash Growth	1,746.16%
Net Debt Equity	$-1.04
Tangible Book Value	$127.4M
Tangible Book Value Per Share	$0.76
WACC	12.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	23.71
Net Working Capital	$-5M
Quick ratio	23.6
Working Capital	$127.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4,310.71%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	59.84%
200-day SMA	1.92
3Y total return	-93.9%
50-day SMA	1.92
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.92%
All Time High	8,182.5
All Time High Change	-99.98%
All Time High Date	2021-04-28
All Time Low	0.53
All Time Low Change	267.92%
All Time Low Date	2025-09-11
ATR	0.16
Beta	1.51
Beta1y	0.66
Beta2y	-0.02
Ch YTD	-17.02
High	2.05
High52	2.86
High52 Date	2026-04-22
High52ch	-31.7%
Low	1.9
Low52	0.53
Low52 Date	2025-09-11
Low52ch	267.93%
Ma50ch	1.83%
Premarket Change Percent	1.49
Premarket Price	$2.05
Premarket Volume	21,704
Price vs 200-day SMA	1.83%
RSI	50.15
RSI Monthly	7.78
RSI Weekly	52.17
Sharpe ratio	0.91x
Sortino ratio	1.68
Total Return	-4,310.71%
Tr YTD	-17.02
Tr1m	0.52%
Tr1w	-1.02%
Tr3m	-10.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	5
Analyst Price Target Top	$11.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.05
Operating Income	$-26.5M
Price target	$10.5
Price Target Change	$438
Price Target Change Top	$474

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	132,942,534%
Float Percent	76.59%
Net Borrowing	-311,000
Shares Insiders	0.38%
Shares Institutions	67.95%
Shares Out	173,579,670
Shares Qo Q	1.99%
Shares Yo Y	4,310.71%
Short Float	24.17%
Short Ratio	7.5
Short Shares	18.51

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.6M
Average Volume	4,859,051x
Bv Per Share	0.76
Ch1m	0.52
Ch1w	-1.02
Ch1y	59.84
Ch3m	-10.14
Ch3y	-93.9
Ch5y	-99.92
Ch6m	2.09
Change	-3.47%
Change From Open	-4.41
Close	2.02
Days Gap	0.99
Depreciation Amortization	2,750
Dollar Volume	4,550,192.4
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-26.5M
EBITDA	$-26.5M
EPS	$-0.23
F Score	2
FCF	$-12.4M
FCF EV Yield	-6.03x
FCF Per Share	$-0.07
Financing CF	137,831,000
Fiscal Year End	December
Founded	1,996
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2024-04-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-20
Ma150	1.92
Ma150ch	1.77%
Ma20	1.99
Ma20ch	-2.01%
Net CF	125,427,000
Next Earnings Date	2026-08-10
Open	2.04
Optionable	No
Position In Range	35.48
Post Close	1.95
Postmarket Change Percent	2.56
Postmarket Price	$2
Pre Close	2.02
Price Date	2026-07-24
Ptbv Ratio	2.66
Relative Volume	0.48x
Share Based Comp	8,183,000
Tr6m	2.09%
Us State	Colorado
Volume	2,333,432

Palisade Bio, Inc. (PALI)

Coverage state: Market snapshot only — no published research

Generate the first PALI analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PALI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PALI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PALI

Frequently asked questions